Shanghai Shen Lian Biomedical Corp (688098) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Shen Lian Biomedical Corp (688098) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥21.52 Million ≈ $3.15 Million USD) by net assets (CN¥1.42 Billion ≈ $207.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Shen Lian Biomedical Corp market cap and net worth for the company's overall valuation and market capitalisation.
Shanghai Shen Lian Biomedical Corp - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Shanghai Shen Lian Biomedical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Shen Lian Biomedical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Shen Lian Biomedical Corp ranked by their cash flow conversion efficiency. Explore Shanghai Shen Lian Biomedical Corp (688098) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cool Company Oy
OL:CLCO
|
0.045x |
|
Ningbo Tianlong Electronics Co Ltd
SHG:603266
|
0.008x |
|
Kaili Catalyst & New Materials Co. Ltd. A
SHG:688269
|
0.008x |
|
Betterware de México, S.A.P.I. de C.V.
NASDAQ:BWMX
|
0.442x |
|
XiAn Catering Co Ltd
SHE:000721
|
-0.313x |
|
Beijing Jingyeda Technology Co Ltd
SHE:003005
|
-0.012x |
|
Shanghai Titan Scientific Co. Ltd. A
SHG:688133
|
0.029x |
|
FIREWEED METALS CORP.
F:M0G
|
-0.215x |
Annual Cash Flow Conversion Efficiency for Shanghai Shen Lian Biomedical Corp (2013–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Shen Lian Biomedical Corp from 2013 to 2025. View 688098 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.40 Billion ≈ $204.71 Million |
CN¥33.08 Million ≈ $4.84 Million |
0.024x | -62.28% |
| 2024-12-31 | CN¥1.43 Billion ≈ $208.61 Million |
CN¥89.36 Million ≈ $13.08 Million |
0.063x | +2579.52% |
| 2023-12-31 | CN¥1.51 Billion ≈ $220.53 Million |
CN¥3.53 Million ≈ $515.90K |
0.002x | -61.47% |
| 2022-12-31 | CN¥1.50 Billion ≈ $219.04 Million |
CN¥9.09 Million ≈ $1.33 Million |
0.006x | -90.08% |
| 2021-12-31 | CN¥1.47 Billion ≈ $215.54 Million |
CN¥90.12 Million ≈ $13.19 Million |
0.061x | -23.54% |
| 2020-12-31 | CN¥1.40 Billion ≈ $204.32 Million |
CN¥111.73 Million ≈ $16.35 Million |
0.080x | +90.53% |
| 2019-12-31 | CN¥1.28 Billion ≈ $187.49 Million |
CN¥53.81 Million ≈ $7.87 Million |
0.042x | -71.15% |
| 2018-12-31 | CN¥831.94 Million ≈ $121.74 Million |
CN¥121.13 Million ≈ $17.73 Million |
0.146x | +7.20% |
| 2017-12-31 | CN¥549.27 Million ≈ $80.38 Million |
CN¥74.61 Million ≈ $10.92 Million |
0.136x | +31.73% |
| 2016-12-31 | CN¥465.47 Million ≈ $68.11 Million |
CN¥48.00 Million ≈ $7.02 Million |
0.103x | +6.05% |
| 2015-12-31 | CN¥317.41 Million ≈ $46.45 Million |
CN¥30.86 Million ≈ $4.52 Million |
0.097x | -77.84% |
| 2014-12-31 | CN¥241.57 Million ≈ $35.35 Million |
CN¥105.98 Million ≈ $15.51 Million |
0.439x | +177.50% |
| 2013-12-31 | CN¥327.59 Million ≈ $47.94 Million |
CN¥51.79 Million ≈ $7.58 Million |
0.158x | -- |
About Shanghai Shen Lian Biomedical Corp
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.